Role and Potential of Artificial Intelligence in Biomarker Discovery and Development of Treatment Strategies for Amyotrophic Lateral Sclerosis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094346 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yoshihiro Kitaoka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuropharmacology, Section of Biosystems and Function, School of Dentistry, University California, Los Angeles, 714 Tiverton, Los Angel…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Biomarkers, Artificial Intelligence. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), present significant challenges owing to their complex pathologies and a lack of curative treatments. Early detection and reliable biomarkers are critical but remain elusive. Artificial intelligence (AI) has emerged as a transformative tool, enabling advancements in biomarker discovery, diagnostic accuracy, and therapeutic development. From optimizing clinical-trial designs to leveraging omics and neuroimaging data, AI facilitates understanding of disease and treatment innovation. Notably, technologies such as AlphaFold and deep learning models have revolutionized proteomics and neuroimaging, offering unprecedented insights into ALS pathophysiology. This review highlights the intersection of AI and ALS, exploring the current state of progress and future therapeutic prospects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neuropharmacology, Section of Biosystems and Function, School of Dentistry, University California, Los Angeles, 714 Tiverton, Los Angeles, CA 90095, USA.
- Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, The University of Osaka, Yamadaoka, Suita 565-0871, Japan.
- Division of Dental Anesthesiology, Faculty of Dentistry, Graduate School of Medicine and Dental Sciences, Niigata University, Niigata 951-8514, Japan.
ORCID-Profile: Yoshihiro Kitaoka, Toru Yamamoto, Shin-Ichiro Hiraoka, Yusuke Yokota, Emiko Tanaka Isomura, Susumu Tanaka, Igor Spigelman, Soju Seki
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kitaoka, Y., Uchihashi, T., Kawata, S., Nishiura, A., Yamamoto, T., Hiraoka, S. I., Yokota, Y., Isomura, E. T., Kogo, M., Tanaka, S., Spigelman, I., & Seki, S. (2025). Role and Potential of Artificial Intelligence in Biomarker Discovery and Development of Treatment Strategies for Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094346
Vancouver
Kitaoka Y, Uchihashi T, Kawata S, Nishiura A, Yamamoto T, Hiraoka SI, et al. Role and Potential of Artificial Intelligence in Biomarker Discovery and Development of Treatment Strategies for Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094346
BibTeX
@article{Kitaoka2025,
author = {Kitaoka, Yoshihiro and Uchihashi, Toshihiro and Kawata, So and Nishiura, Akira and Yamamoto, Toru and Hiraoka, Shin-Ichiro and Yokota, Yusuke and Isomura, Emiko Tanaka and Kogo, Mikihiko and Tanaka, Susumu and Spigelman, Igor and Seki, Soju},
title = {Role and Potential of Artificial Intelligence in Biomarker Discovery and Development of Treatment Strategies for Amyotrophic Lateral Sclerosis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094346}
}
EUVIMED